Novel Statistical Analyses to Assess Hearing Outcomes After ABI Implantation in NF2 Patients: Systematic Review and Individualized Patient Data Analysis
Shervin Taslimi(Kingston General Hospital), Farhad Pirouzmand(Sunnybrook Health Science Centre), Alireza Mansouri(Penn State Milton S. Hershey Medical Center), Laureen D. Hachem(University of Toronto), Jeffrey Zuccato(University of Oklahoma Health Sciences Center), Jetan H. Badhiwala(University of Toronto), Joseph Chen(Pfizer (United States)), Johannes Kuchta(University of Cologne)
Cited by 6
Related Papers
Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes
|Nature Medicine|2020|270
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results
|Nature Medicine|2023|125
The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care
|Clinical Epigenetics|2019|89
The Impact of Early Medical School Surgical Exposure on Interest in Neurosurgery
|Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques|2015|79